IVUS is a powerful tool for evaluating ostial lesions 4, 35% (2/46); superficial cancification 19, 56% (9/46); mural thrombus 2, 17% (1/46) and vulnerable lesions 2, 17% (1/46) in which coronary angiography can not reveal.